Hutch News

Hutch News

Stories tagged 'immunotherapy'

Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech

Fred Hutch experts lend their predictions for the coming year’s advances

Jan. 12, 2018 | By Rachel Tompa / Fred Hutch News Service

We asked Fred Hutch researchers for their predictions on scientific advances to watch in the coming year. Look for their tips on what's next in cancer immunotherapy, precision oncology, gene editing, infectious disease research, cancer prevention and more.

View story >


Stem cell transplantation physician-scientist recruited from Australia to join Fred Hutch, SCCA

Dr. Geoffrey Hill will help integrate bone marrow transplantation with emerging cancer immunotherapies

Dec. 7, 2017 | By Molly McElroy

Fred Hutchinson Cancer Research Center is appointing world-renowned blood stem cell transplantation physician-scientist Dr. Geoffrey Hill to be director of Hematopoietic Stem Cell Transplantation, effective July 1.

View story >


The latest in gynecological cancer research from the Pacific Northwest

Inaugural Northwest Gynecological Cancer Symposium brings together scientists studying ovarian, cervical and endometrial cancers

Dec. 6, 2017 | By Rachel Tompa / Fred Hutch News Service

Monday, cancer researchers from around the Pacific Northwest gathered at Fred Hutchinson Cancer Research Center to discuss their latest efforts to better prevent, detect and treat cancers of the female reproductive tract in the inaugural Northwest Gynecological Cancer Symposium.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Nov. 30, 2017

The Parker Institute for Cancer Immunotherapy announced that Dr. Phil Greenberg, head of the Program in Immunology at the Hutch, has joined its team of more than 300 scientists from the academic, nonprofit, biotech and pharma sectors.

View story >


For cancer patients with HIV, immunotherapy appears safe

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials

Nov. 7, 2017 | By Mary Engel / Fred Hutch News Service

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.

View story >


First systematic study of infections after CAR T-cell therapy

“Benchmark” research could help reduce complications of emerging immunotherapy

Nov. 6, 2017 | by Susan Keown / Fred Hutch News Service

The first detailed study of infections after CAR T-cell therapy could help researchers improve the safety of this emerging type of genetically engineered cell therapy for cancer.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.